Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Valproic Acid Plus Retinoic Acid Induce Myeloid Differentiation in Chemotherapy-Resistant Acute Myeloid Leukemia Patients.

C. Nervi, MD, F. Lo Coco, MD, S. Minucci, MD, A. Careddu tech., R. Fiorini, MD, E. Finolezzi, MD, N. Noguera, PHD, L. Travaglini, PHD, V. Gelmetti, PHD, D. Diverio, PHD, S. Fenu, MD, M. Mancini, MD, C. Tatarelli, MD, M.A. Aloe Spiriti, MD, M.C. Petti, MD, G. Cimino, MD, F. Mandelli, MD, S. Amadori, MD, P.G. Pelicci, MD

Blood (2004) 104 (11): 1805.

https://doi.org/10.1182/blood.V104.11.1805.1805

Published: 2004

Journal Articles

The PML/RAR alpha oncoprotein is a direct molecular target of retinoic acid in acute promyelocytic leukemia cells

JV Raelson, C Nervi, A Rosenauer, L Benedetti, Y Monczak, M Pearson, PG Pelicci, WH Jr Miller

Blood (1996) 88 (8): 2826–2832.

https://doi.org/10.1182/blood.V88.8.2826.bloodjournal8882826

Published: 1996

Journal Articles

Alterations in expression, binding to ligand and DNA, and transcriptional activity of rearranged and wild-type retinoid receptors in retinoid-resistant acute promyelocytic leukemia cell lines

A Rosenauer, JV Raelson, C Nervi, P Eydoux, A DeBlasio, WH Jr Miller

Blood (1996) 88 (7): 2671–2682.

https://doi.org/10.1182/blood.V88.7.2671.bloodjournal8872671

Published: 1996

Journal Articles

Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARalpha-mediated increase of type II transglutaminase

L Benedetti, F Grignani, BM Scicchitano, AM Jetten, D Diverio, F Lo Coco, G Avvisati, C Gambacorti-Passerini, S Adamo, AA Levin, PG Pelicci, C Nervi

Blood (1996) 87 (5): 1939–1950.

https://doi.org/10.1182/blood.V87.5.1939.1939

Published: 1996

Journal Articles

Occurrence of resistance to retinoic acid in the acute promyelocytic leukemia cell line NB4 is associated with altered expression of the pml/RAR alpha protein

S Dermime, F Grignani, M Clerici, C Nervi, G Sozzi, GP Talamo, E Marchesi, F Formelli, G Parmiani, PG Pelicci, C Gambacorti-Passerini

Blood (1993) 82 (5): 1573–1577.

https://doi.org/10.1182/blood.V82.5.1573.1573

Published: 1993

NARROW

Valproic Acid Plus Retinoic Acid Induce Myeloid Differentiation in Chemotherapy-Resistant Acute Myeloid Leukemia Patients.

The PML/RAR alpha oncoprotein is a direct molecular target of retinoic acid in acute promyelocytic leukemia cells

Alterations in expression, binding to ligand and DNA, and transcriptional activity of rearranged and wild-type retinoid receptors in retinoid-resistant acute promyelocytic leukemia cell lines

Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARalpha-mediated increase of type II transglutaminase

Occurrence of resistance to retinoic acid in the acute promyelocytic leukemia cell line NB4 is associated with altered expression of the pml/RAR alpha protein

Email alerts

ASH Publications

American Society of Hematology

Valproic Acid Plus Retinoic Acid Induce Myeloid Differentiation in Chemotherapy-Resistant Acute Myeloid Leukemia Patients.

The PML/RAR alpha oncoprotein is a direct molecular target of retinoic acid in acute promyelocytic leukemia cells

Alterations in expression, binding to ligand and DNA, and transcriptional activity of rearranged and wild-type retinoid receptors in retinoid-resistant acute promyelocytic leukemia cell lines

Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARalpha-mediated increase of type II transglutaminase

Occurrence of resistance to retinoic acid in the acute promyelocytic leukemia cell line NB4 is associated with altered expression of the pml/RAR alpha protein

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only